Rossari Biotech Limited Stock Debt To Equity

ROSSARI Stock   826.15  18.40  2.18%   
Rossari Biotech Limited fundamentals help investors to digest information that contributes to Rossari Biotech's financial success or failures. It also enables traders to predict the movement of Rossari Stock. The fundamental analysis module provides a way to measure Rossari Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rossari Biotech stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Rossari Biotech Limited Company Debt To Equity Analysis

Rossari Biotech's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

 = 

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition

Rossari Total Stockholder Equity

Total Stockholder Equity

11 Billion

As of now, Rossari Biotech's Total Stockholder Equity is increasing as compared to previous years.
According to the company disclosure, Rossari Biotech Limited has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Chemicals sector and 100.0% lower than that of the Materials industry. The debt to equity for all India stocks is 100.0% higher than that of the company.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Rossari Fundamentals

About Rossari Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rossari Biotech Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rossari Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rossari Biotech Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Rossari Stock

Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.